1. Centers for Disease Control and Prevention (2007) Epidemiology and prevention of vaccine-preventable diseases, 10th edn. Atkinson W, Hamborsky J, McIntyre L, Wolfe S (eds). Public Health Foundation, Washington, DC
2. Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV (2003) Tetanus surveillance—United States, 1998—2000. MMWR Surveill Summ 52(3):1–8
3. Centers for Disease Control and Prevention (2003) Recommended childhood immunization schedule—United States, 2003. MMWR Morb Mortal Wkly Rep 52:Q1–Q4
4. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee (2006) Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55(RR-17):1–37
5. Gergen PJ, McQuillan GM, Kiely M et al (1995) A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 332:761–766